As with other incretin-based therapies, retatrutide is associated with a range of side effects, the majority of which are gastrointestinal in nature and tend to be most pronounced during the dose-escalation phase
Weghuber D, Barrett T, Barrientos-Prez M, Gies I, Hesse D, Jeppesen OK, Kelly AS, Mastrandrea LD, Srrig R, Arslanian S
Allow a 14-21 day washout period before restarting any GH secretagogue protocol to ensure GHRH receptor density has returned to pre-cycle levels
We partner directly with trusted manufacturers to maintain strict standards of purity and consistency, with high-performance liquid chromatography (HPLC) testing conducted on select batches
Never Double-Dose : Taking two doses to catch up increases side effect risks